SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,588,901 | -67.4% | 2,916,471 | -42.3% | 0.00% | -100.0% |
| Q3 2022 | $7,933,000 | -12.9% | 5,052,863 | +11.6% | 0.00% | -66.7% |
| Q2 2022 | $9,104,000 | -16.9% | 4,529,040 | -3.6% | 0.00% | +50.0% |
| Q1 2022 | $10,949,000 | -67.8% | 4,699,295 | -35.7% | 0.00% | +100.0% |
| Q4 2021 | $34,010,000 | +26.8% | 7,313,914 | +108.0% | 0.00% | -75.0% |
| Q3 2021 | $26,830,000 | -35.2% | 3,516,389 | -17.7% | 0.00% | -33.3% |
| Q2 2021 | $41,425,000 | +48.0% | 4,275,093 | +26.3% | 0.01% | +50.0% |
| Q1 2021 | $27,993,000 | -54.6% | 3,384,839 | -62.6% | 0.00% | -20.0% |
| Q4 2020 | $61,712,000 | -8.0% | 9,042,094 | +50.3% | 0.01% | -58.3% |
| Q3 2020 | $67,082,000 | +244.4% | 6,016,328 | +94.0% | 0.01% | +140.0% |
| Q2 2020 | $19,479,000 | +1365.7% | 3,101,743 | +329.4% | 0.01% | – |
| Q1 2020 | $1,329,000 | -27.1% | 722,361 | +33.8% | 0.00% | – |
| Q4 2019 | $1,824,000 | +86.5% | 539,742 | +18.1% | 0.00% | – |
| Q3 2019 | $978,000 | -66.5% | 457,020 | -58.2% | 0.00% | – |
| Q2 2019 | $2,918,000 | +46.2% | 1,092,479 | +160.0% | 0.00% | – |
| Q1 2019 | $1,996,000 | +961.7% | 420,110 | +437.9% | 0.00% | – |
| Q4 2018 | $188,000 | -63.2% | 78,100 | -32.8% | 0.00% | – |
| Q3 2018 | $511,000 | -84.1% | 116,300 | -74.0% | 0.00% | -100.0% |
| Q2 2018 | $3,215,000 | +87.4% | 446,600 | +34.1% | 0.00% | – |
| Q1 2018 | $1,716,000 | +167.7% | 333,123 | +97.5% | 0.00% | – |
| Q4 2017 | $641,000 | +567.7% | 168,661 | +200.0% | 0.00% | – |
| Q3 2017 | $96,000 | -68.6% | 56,214 | -63.2% | 0.00% | – |
| Q2 2017 | $306,000 | -0.6% | 152,787 | +143.0% | 0.00% | – |
| Q4 2016 | $308,000 | -42.0% | 62,886 | -8.3% | 0.00% | – |
| Q3 2016 | $531,000 | +276.6% | 68,600 | +172.8% | 0.00% | – |
| Q2 2016 | $141,000 | -46.8% | 25,151 | -48.8% | 0.00% | – |
| Q1 2016 | $265,000 | -50.3% | 49,149 | -19.7% | 0.00% | – |
| Q4 2015 | $533,000 | -76.7% | 61,222 | -77.5% | 0.00% | – |
| Q3 2015 | $2,288,000 | -17.5% | 272,649 | +73.2% | 0.00% | -100.0% |
| Q2 2015 | $2,774,000 | 0.0% | 157,457 | -34.4% | 0.00% | 0.0% |
| Q1 2015 | $2,774,000 | +894.3% | 239,869 | +1003.2% | 0.00% | – |
| Q1 2014 | $279,000 | -36.2% | 21,743 | -59.7% | 0.00% | – |
| Q4 2013 | $437,000 | – | 53,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |